Skip to search formSkip to main contentSkip to account menu

Potassium bitartrate 900 MG / Sodium Bicarbonate 600 MG Rectal Suppository [Ceo-Two]

Known as: K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two], POTASSIUM BITARTRATE 927 mg in 3.7 g / SODIUM BICARBONATE 618 mg in 3.7 g RECTAL SUPPOSITORY [CEO-TWO], Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ceria nanostructure-based catalysts have attracted much attention in recent years because of their unique physiochemical… 
2013
2013
The effect of top management change on firm performance remains a debate in spite of a number of studies and renewed attention to… 
2013
2013
This research study sheds light on the link between different board structure attributes and financial performance among 40 firms… 
2012
2012
A CeO-Cuo nanocomposites have been synthesized by a Sol-Gel method based on polymeric network of polyvinyl alcohol (PVA)In this… 
2009
2009
The aim of this research is to identify the key elements in the success of business models for companies producing open source… 
2006
2006
An emerging class of highly specific immunomodulator drugs targeting toll-like receptors will be the focus of attention this… 
2002
2002
The CEO departure is an important mechanism in corporate governance. It is by using this mechanism that boards of directors may… 
1986
1986
Published results and work from this laboratory permit the characterization of the possible promutagenic lesions induced by…